To Schedule more than 600 Scientific/Tech and Business/Economics/Policy Presentations on Frontier of Vaccinology and Vaccine Development from World Class Scientists, Executives and Decision Makers
To call for 200 Poster Demonstration and 100 Expositions of New Products and Technologies to Expand Visibilities to the up to 3000 Targeted Audiences
To Provide Five Training Courses and Special Workshop to Serve Educational Purposes
To Arrange Round Table Network for Business and Market Development
5 workshops and 12 Remarkable Tracks Cover a Broad Spectrum of Current Advances and Status of Vaccinology and Vaccine Development in not only Human Vaccine Field, but also to extend to Livestock, Agricultural and Aquaculture Vaccine R & D and Business Development.
One Special Symposium dedicated for Young Investigators, Postdoc, Graduate Students to Report their Current Status of Research
Honorary Forum for A Great Scientist with Life Long Achievement
Integrate Career Fair, Poster Sessions and Tech/Product Exposition for Both Academia and Industries.
One Art Performance Activities for Welcome Banquet and Closing Ceremony
Tech Tour in Beijing, Xi'an, Hangzhou, Guilin and Kunming, China
Keynote Speakers
Dr. Michel De Wilde, Senior Vice President of Research & Development, Sanofipasteur, France
Dr. John W. Shiver, Vice President & Worldwide Basic Research Franchise Head, Vaccines. Merck & Co., Inc., USA
Dr. Rahul Singhvi, CEO & President, Novavax Inc., USA
Dr. Wen Yumei, Academician, Chinese Academy of Engineering, China
BIT’s 2nd Annual World Congress of Vaccine (WCV-2010), with a theme of “Next Generation of Vaccines” was successfully held during March 23-25, 2010 in Beijing, China. WCV-2010 was jointly held with the 2nd Annual Congress of Antibodies (ICA-2010); these two conferences brought together more than 1000 participants and 100 exhibitors from 46 countries and regions all over the world. Dr. Roy Curtiss III,Academician, United States National Academy of Sciences, USA; Dr. John B Robbins, Senior Investigator, National Institute of Health, 1996 Albert Lasker Medical Award Winner, USA; Dr. Dexian Zheng, Vice President, Chinese Society for Immunolgy, China; Dr. Jeffrey Almond, Vice President, Global Research and External Research and Development, Sanofi-Pasteur, France; Dr. Jean-Paul Prieels, Senior Vice President, Research & Development, GlaxoSmithKline Biologicals, Belgium; Dr. Peter H. Khoury, Vice President, Global Marketing Baxter BioScience, Vaccines, USA; gave wonderful keynote speeches during the conference.More...
WCV-2011 provides an ideal platform to showcase your novel technologies and products in China. It is developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee breaks and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits.
Why Reserve a Booth at WCV-2011
To Meet Face-to-Face with the International Movers and
Shakers in the Field of Vaccine Science and Technology
To Meet with Key Decision Marker around the World
To Explore Business Opportunities in China and Beyond
To Spotlight Advanced Technologies and Their Scientific and
Commercial Applications
To Take Advantage of the Conference's Captive Audience
and Networking Opportunities within the Exhibition Hall
Tech-Tour
Hosting Organization
Information Research Center of International Talent, SAFEA
Operating Organization
BIT Life Sciences, Inc.
Foreign Experts Databank
of SAFEA-Dalian Biotechnological and Medical Experts Subdivision
Supporting Organization
China Council for the Promotion of International Trade China Chamber of International Commerce Dalian Branch
Past Exhibitors
Organization Participated
GlaxoSmithKline Biologicals, Belgium
Pfizer, USA
Merck, USA
Novartis AG, Switzerland
Sanofi Pasteur, France
Sanofi-Aventis, France
MedImmune, USA
Baxter, USA
Novozymes A/S, Denmark
Wyeth, USA
Intercell, Austria
Crucell, Netherlands
VaxInnate, Inc., USA
Shenzhen Polytechnic, China
Medicago Inc, Canada
Novartis Vaccines, USA
Cyto Pulse Sciences, Inc., USA
GlaxoSmithKline Biologicals, USA
Selecta Biosciences Inc., USA
Petrovax Group, Russia
Becton,Dickinson & Company, USA
TechnoVax, USA
Antagen Biosciences, Inc., USA
Apogee Technology, Inc, USA
Acambis, UK
Chiron, USA
3M, USA
CSC, USA
AlphaVax, USA
Emergent BioSolutions, UK
Hawaii Biotech, USA
Arbovax, Inc, USA
PATH, USA
Sigma-Aldrich, USA
Duke-NUS, Singapore
TechnoVax, Inc., USA
Medicago Inc, Canada
Kotwal Bioconsulting, LLC, USA
MedImmune Vaccine, USA
Synergy America, Inc., USA
VPM Inc., Germany
Shanghai H&G Biotechnology Inc., China
Oxford-Emergent Tuberculosis Consortium Ltd, UK
Theraclone Sciences, Inc, USA
Green Cross Therapeutics Pvt Ltd, India
DanDrit Biotech, Denmark
Crossbeta Biosciences B.V., The Netherlands
Transgene S.A., France
TD Consultancy, LLC, USA
BioReliance, UK
Biosante Pharmaceuticals, USA
Vaxgen Corporation, USA
AXIO International, France
Charles River Avian Products and Services, USA
Strategic Manufacturing Worldwide, Inc., USA
GE Healthcare Life Sciences, Sweden
GE Healthcare Life Sciences,China
Althea Technologies Inc., USA
immatics biotechnologies GmbH,Germany
Green Hills Biotechnology GmbH, Austria
Gan Shmuel, Israel
SIOGEN Biotech, Malaysia
OptiNose AS, Norway
Civimetrix, Canada
Apotex, Canada
Biovet Pvt Ltd, India
BD Technologies,
University of Lille2 and University of Artois, France
Ghent University, Belgium
Chicago Medical School, USA
National University of Colombia, Colombia
Army Medical Research Institute of Infectious Diseases, USA
European Commission Joint Research Center, Italy
University of Arkansas for Medical Sciences, USA
Mount Sinai School of Medicine, USA
University of New South Wales, Australia
Chinese Academy of Engineering, China
CrucellBerna Biotech Korea, Korea
Pomeranian Medical University, Poland
Public Health Service, The Netherlands
University of New South Wales, Australia
The Wistar Institute, USA
Kamineni Institute of Medical Sciences, India
RMIT University, Australia
National Taiwan University, Taiwan
University of Indonesia, Indonesia
World Health Organization, Switzerland
Russian Academy of Medical Sciences, Russian Federation
National Tsing Hua University, Taiwan
University of California, Davis, USA
Kuwait University, Kuwait
Lanzhou University, China
Texas Tech University Health Sciences Center, USA
Queensland Institute of Medical Research, Australia
French National Academy of Medicine, France
New York University, USA
Harvard Medical School, USA
D Cotugno Hospital, Italy
Chiang Mai University, Thailand
The Ohio State University, USA
Deakin University, Australia.
Vrije Universiteit Brussel, Belgium
University of Paris, France
University of Southampton, UK
University of Ulm, Germany
National Cancer Research Center, Serbia
World Health Organisation (WHO), Uganda
Cornell University, USA
Hacettepe University, Turkey
Tel Aviv University, Israe
National Institute of Hygiene, Morocco
International Vaccine Institute
International AIDS Vaccine Institute
Global TB Vaccine Foundation
Bill & Melinda Gates Foundation, USA
Center for Disease Control and Prevention, China
Center for Disease Control and Prevention, USA
Children’s Global Health Initiative, USA
Vaccine and Infectious Disease Organization, Canada
Sabin Vaccine Institute, USA
National Institutes of Health , USA
National Human Genome Research, USA
National Vaccine and Serum Institute, China
Karolinska Institute, Sweden
Anderson Cancer Center, USA
Albert Einstein College of Medicine, USA
Oxford University, UK
Institute Pasteur, France
Tufts University, USA
Tufts University School of Medicine, USA
Fudan University, China
University of Missouri-Columbia, USA
Aarhus University Hospital – Skejby, Denmark
Baylor College of Medicine, USA
Fraunhofer USA CMB, USA
INSERM, France
Arizona State University, USA
Uppsala University, Sweden
US Army Medical Research Institute of Infectious Diseases, USA
Arizona State University, USA
University of Calgary, Canada
Gold Coast Campus, Australia
University of Calgary, Canada
National Health Research Institutes,Taiwan
Netherlands Vaccine Institute, Netherlands
Chungnam National University, Korea
The University of Sydney, Australia
Queen Mary University of London, UK
University of Lille2 and University of Artois, France
Ghent University, Belgium
Chicago Medical School, USA
National University of Colombia, Colombia
Army Medical Research Institute of Infectious Diseases, USA
European Commission Joint Research Center, Italy
University of Arkansas for Medical Sciences, USA
Mount Sinai School of Medicine, USA
University of New South Wales, Australia
Chinese Academy of Engineering, China
CrucellBerna Biotech Korea, Korea
Pomeranian Medical University, Poland
Public Health Service, The Netherlands
University of New South Wales, Australia
The Wistar Institute, USA
Kamineni Institute of Medical Sciences, India
RMIT University, Australia
National Taiwan University, Taiwan
University of Indonesia, Indonesia
World Health Organization, Switzerland
Russian Academy of Medical Sciences, Russian Federation
National Tsing Hua University, Taiwan
University of California, Davis, USA
Kuwait University, Kuwait
Lanzhou University, China
Texas Tech University Health Sciences Center, USA
Queensland Institute of Medical Research, Australia
`
